| Code | CSB-AP003961HU |
| Abbreviation | Recombinant Human TGFB2 protein, partial (Active) |
| MSDS | |
| Size | $290 |
| Order now | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
TGF-β2 plays a central role in immunosuppression and tumor microenvironment remodeling, making it a critical tool for dissecting glioblastoma biology and broader cancer signaling. This tag-free recombinant human TGFB2 encompasses the mature signaling domain (aa 303–414) and demonstrates potent bioactivity, with an ED50 of 30–180 pg/mL in inhibiting IL-4-dependent TF-1 cell proliferation — a level of receptor-binding potency that supports use in cell proliferation assays, stem cell or neuronal differentiation studies, and in vivo tumor biology models. Mammalian cell expression preserves native-like glycosylation and disulfide bonding essential for proper TGF-β2 folding and receptor engagement, providing a suitable basis for receptor-ligand binding experiments such as SPR and competition ELISA, as well as antibody characterization workflows. Purity exceeding 95% by SDS-PAGE combined with endotoxin levels below 1.0 EU/μg satisfies the quality criteria typical for cell-based bioassays and sensitive in vivo studies.
There are currently no reviews for this product.